<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77299">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01992445</url>
  </required_header>
  <id_info>
    <org_study_id>20133770</org_study_id>
    <nct_id>NCT01992445</nct_id>
  </id_info>
  <brief_title>Suicidal Thought and Biological Markers</brief_title>
  <acronym>STM</acronym>
  <official_title>Suicidal Thought and Biological Markers: A Prospective Multicenter Study Validating Verbal, Non-verbal and Genetic Methods to Assess Suicidal Intent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop a predictive model that includes Thought Markers
      (Tm) and Biomarkers(Bm) to accurately predict the likelihood of a repeated suicide attempt.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Columbia Suicide Severity Rating Scale</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acoustic analysis of voice</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Voice recording</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Video analysis</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Video recording</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DNA analysis</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>DNA analysis</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Suicidal Intent</condition>
  <arm_group>
    <arm_group_label>Suicidal</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Other mental health</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Control (non suicidal, non mental health)</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Buccal swabs
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Emergency Department and inpatients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        oBe able to understand the requirements of the study and provide written informed consent
        to participate in this study. Signed and dated informed consent will be obtained from each
        patient before participation in the study, oHave provided written authorization for the
        use and disclosure of their protected health information, oBe 13 years of age or older,
        oBe diagnosed with: oSuicide ideation/attempts/gestures, or oNon-suicidal and having other
        mental disorders, oNon-mentally ill, and non-suicidal controls, oSpeak English as the
        primary language in the home, oAgree to abide by the study protocol and its restrictions
        and be able to complete all  aspects of the study.

        Exclusion Criteria:

        oSignificant unstable medical condition that may obscure the scientific interpretability
        of the study or unduly increase the risks of the protocol, oAnticipated inability to
        attend follow-up phone interview, oPatients whose level of consciousness precludes consent
        and research assessments, oPatients unable to assent because of severe mental retardation,
        oPatients who in the judgment of the Investigator may be unreliable or uncooperative with
         the evaluation procedure outlined in this protocol, oFor control patients a diagnosis of
        depression or another non-mental illness, or a history  of suicidal behavior or suicidal
        attempt, oPatients who are unwilling to provide the DNA sample.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Pestian, PhD</last_name>
    <role>Study Director</role>
    <affiliation>CCHMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Colleen Murphy, MAT, CCRP</last_name>
    <email>colleen.murphy@cchmc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>CCHMC</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>John Pestian, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princeton Community Hospital</name>
      <address>
        <city>Princeton</city>
        <state>West Virginia</state>
        <zip>24740</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jeffry Gee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 19, 2013</lastchanged_date>
  <firstreceived_date>November 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>suicide</keyword>
  <keyword>suicidal intent</keyword>
  <keyword>thought markers</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Suicidal Ideation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
